SOW
CTMX icon

State of Wyoming’s CytomX Therapeutics CTMX Stock Holding History

State of Wyoming’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Buy
54,987
+2,295
+4% +$8.76K 0.02% 1001
2026
Q1 		$248K Buy
52,692
+31,181
+145% +$158K 0.03% 800
2025
Q4 		$91.6K Buy
+21,511
New +$81.7K 0.01% 1322
2022
Q3 		– Sell
-23,709
Closed -$43K – 1607
2022
Q2 		$43K Buy
+23,709
New +$45.4K 0.03% 1029

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

State of Wyoming's CTMX Position: Q2 2026 in Review

State of Wyoming increased its CytomX Therapeutics (CTMX) stake by 4.4% in Q2 2026, buying an estimated $8.76K and bringing the position to 54,987 shares worth $206K. The position accounts for 0.02% of the portfolio, ranked #1001.

State of Wyoming first reported a position in CTMX in Q2 2022 and has held it in 4 quarters since. The position peaked at $248K in Q1 2026. 178 funds tracked by Wall St. Rank hold CTMX as of Q2 2026.

  • State of Wyoming held 54,987 shares of CytomX Therapeutics worth $206K as of Q2 2026.
  • State of Wyoming bought 2,295 CytomX Therapeutics shares in Q2 2026, an estimated $8.76K.
  • CytomX Therapeutics made up 0.02% of State of Wyoming's portfolio in Q2 2026, its #1001 holding.
  • State of Wyoming first reported a position in CytomX Therapeutics in Q2 2022 and has held it in 4 quarters since.
  • State of Wyoming's CytomX Therapeutics position peaked at $248K in Q1 2026.
  • 178 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.